dopexamine has been researched along with Disease Models, Animal in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (66.67) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Abbott, TEF; Bangash, MN; Hinds, CJ; Patel, NSA; Pearse, RM; Thiemermann, C | 1 |
| Andreadou, I; Chondroudaki, I; Costopanagiotou, C; Doufas, A; Kostopanagiotou, G; Kotsis, T; Pandazi, A; Rizos, D; Smyrniotis, V | 1 |
| Birnbaum, J; Grundling, M; Hein, OV; Klotz, E; Kox, WJ; Lehmann, C; Lorenz, B; Pavlovic, D; Spies, CD; Stuebs, P; Usichenko, T; Wendt, M | 1 |
| Chintala, MS; Jandhyala, BS; Lokhandwala, MF; Moore, RJ | 1 |
| Eleno, N; Gömez-Garre, DN; López-Farré, A; López-Novoa, JM | 1 |
| Höckerstedt, K; Mäkisalo, H; Mildh, L; Nordin, A | 1 |
| Bonatti, J; Deusch, E; Furtner, B; Germann, R; Gruber, E; Haisjackl, M; Hasibeder, W; Hausdorfer, H; Meusburger, S; Pajk, W; Schwarz, B; Ulmer, H | 1 |
| Bone, HG; Booke, M; Meissner, A; Meyer, J; Prien, T; Van Aken, H; Waurick, R | 1 |
| Choe, EU; Ferrara, JJ; Flint, LM; Mero, KA | 1 |
| Bennett, ED | 1 |
| Gebhard, MM; Häcker, A; Martin, E; Schmidt, H; Schmidt, W | 1 |
| Madorin, WS; Martin, CM; Sibbald, WJ | 1 |
| Aliabadi-Wahle, S; Choe, EU; Ferrara, JJ; Flint, LM | 1 |
| Gebhard, MM; Martin, E; Ortanderl , JM; Schmidt, H; Schmidt, W; Secchi, A; Walther, A | 1 |
| Alhan, E; Cicek, R; Deger, O; Erçin, C; Küçüktülü, U | 1 |
| Guignard, JP; Jaton, T; Thonney, M | 1 |
| Barnes, PJ; Evans, TW; McCormack, DG | 1 |
1 review(s) available for dopexamine and Disease Models, Animal
| Article | Year |
|---|---|
Dopexamine: much more than a vasoactive agent.
Topics: Adrenergic beta-Agonists; Animals; Anti-Inflammatory Agents; Capillary Permeability; Disease Models, Animal; Dopamine; Humans; Leukocytes; Mice; Rats; Sepsis; Swine; Vasodilator Agents | 1998 |
17 other study(ies) available for dopexamine and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
The Effect of β
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Cell Adhesion; Disease Models, Animal; Dopamine; Endothelial Cells; Endotoxemia; Humans; Laparotomy; Leukocytes; Male; Microcirculation; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Vasodilator Agents | 2020 |
Effects of dopexamine on lipid peroxidation during aortic surgery in pigs: comparison with dopamine.
Topics: Animals; Aortic Aneurysm, Abdominal; Biomarkers; Disease Models, Animal; Dopamine; Dopamine Agonists; Follow-Up Studies; Infusions, Intravenous; Lipid Peroxidation; Malondialdehyde; Prospective Studies; Random Allocation; Reperfusion Injury; Swine; Vascular Surgical Procedures | 2005 |
Effects of dopexamine on the intestinal microvascular blood flow and leukocyte activation in a sepsis model in rats.
Topics: Animals; Disease Models, Animal; Dopamine; Intestinal Mucosa; Intestines; Leukocytes; Male; Microcirculation; Rats; Rats, Wistar; Regional Blood Flow; Sepsis | 2006 |
Evaluation of the effects of dopexamine, a novel DA1 receptor and beta 2-adrenoceptor agonist, on cardiac function and splanchnic circulation in a canine model of hemorrhagic shock.
Topics: Adrenergic beta-Agonists; Animals; Disease Models, Animal; Dogs; Dopamine; Dopamine Agents; Heart; Hemodynamics; Shock, Hemorrhagic; Splanchnic Circulation | 1993 |
Comparative effects of dopexamine and dopamine on glycerol-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Adrenergic beta-Agonists; Animals; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Evaluation, Preclinical; Glomerular Filtration Rate; Glycerol; Male; Rats; Rats, Wistar; Renal Plasma Flow; Time Factors | 1996 |
Dopexamine improves liver oxygenation during crystalloid resuscitation from experimental hemorrhagic shock.
Topics: Adrenergic beta-Agonists; Animals; Biological Transport; Crystalloid Solutions; Disease Models, Animal; Dopamine; Isotonic Solutions; Liver; Liver Circulation; Oxygen; Plasma Substitutes; Rabbits; Random Allocation; Resuscitation; Shock, Hemorrhagic; Swine | 1997 |
Inotropic treatment and intestinal mucosal tissue oxygenation in a model of porcine endotoxemia.
Topics: Animals; Blood Gas Analysis; Disease Models, Animal; Dobutamine; Dopamine; Endotoxemia; Evaluation Studies as Topic; Female; Hemodynamics; Intestinal Mucosa; Male; Oxygen Consumption; Prospective Studies; Random Allocation; Swine; Vasodilator Agents | 1997 |
Haemodynamic effects of dopexamine and nitric oxide synthase inhibition in healthy and endotoxaemic sheep.
Topics: Adrenergic beta-Agonists; Animals; Disease Models, Animal; Dopamine; Endotoxemia; Endotoxins; Enzyme Inhibitors; Female; Hemodynamics; Infusions, Intravenous; Lung; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Salmonella typhi; Sheep; Vasodilator Agents | 1997 |
Indomethacin-induced reduction in neonatal piglet mesenteric blood flow is blunted by dopexamine.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dopamine; Drug Interactions; Indomethacin; Injections, Intravenous; Random Allocation; Reference Values; Splanchnic Circulation; Swine | 1998 |
Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bacteremia; Capillary Permeability; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Escherichia coli Infections; Leukocytes; Male; Mesentery; Microcirculation; Propanolamines; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2; Vasodilator Agents | 1998 |
Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis.
Topics: Animals; Arterioles; Blood Flow Velocity; Cross-Over Studies; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Ileum; Intestinal Mucosa; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sepsis; Vasodilator Agents | 1999 |
Post-treatment dopexamine infusions partially reverse reductions in cranial mesenteric blood flow and mucosal oxygenation induced by hypoxia in newborn piglets.
Topics: Adrenergic beta-Agonists; Animals; Animals, Newborn; Disease Models, Animal; Dopamine; Dopamine Agonists; Hypoxia; Intestinal Mucosa; Mesentery; Regional Blood Flow; Swine | 1999 |
Effects of dobutamine and dopexamine on hepatic micro- and macrocirculation during experimental endotoxemia: an intravital microscopic study in the rat.
Topics: Adrenergic beta-Agonists; Animals; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dopamine; Drug Evaluation, Preclinical; Drug Monitoring; Endotoxemia; Heart Rate; Infusions, Intravenous; Liver Circulation; Male; Microcirculation; Random Allocation; Rats; Rats, Wistar | 2001 |
Effects of dopexamine on acute necrotising pancreatitis in rats.
Topics: Amylases; Animals; Blood Gas Analysis; Ceruletide; Disease Models, Animal; Dopamine; Hemodynamics; Male; Microcirculation; Oxygen Consumption; Pancreas; Pancreatitis, Acute Necrotizing; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric | 2001 |
Failure of dopexamine to protect the hypoxemic newborn rabbit kidney.
Topics: Animals; Animals, Newborn; Blood Pressure; Disease Models, Animal; Dopamine; Dopamine Agents; Hypoxia; Kidney; Kidney Diseases; Oxygen; Partial Pressure; Rabbits; Renal Circulation; Vascular Resistance | 1991 |
Effects of dopexamine hydrochloride on hypoxic pulmonary vasoconstriction in isolated rat lung.
Topics: Animals; Dinoprost; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Hypoxia; Lung; Lung Diseases; Male; Propranolol; Rats; Rats, Inbred Strains; Respiration, Artificial; Vasoconstriction; Vasodilator Agents | 1990 |